Slide

This was World Cancer Day 2023!
See the recording (in French), or read more about it here.

TAD07201
Afbeelding van WhatsApp op 2023-12-20 om 15.51.20_7601f930
Afbeelding van WhatsApp op 2023-12-20 om 15.51.12_4dd3ae3d
TAD06892
TAD06885
Second International Conference on Sexual Dimorphism in Cancer
Second International Conference on Sexual Dimorphism in Cancer

The field of Sexual Dimorphism in Cancer has seen significant advancements, with disparities in cancer incidence, survival rates, and treatment effectiveness being actively researched. The conference focuses on the impact of sex hormones and chromosomes on cancer susceptibility, with an emphasis on (epi)genetics, sex hormones, cancer cell biology, metabolism and the immune system.

Membership
Become a member
Be part of a local network of like-minded people and connect to a broad community with the same goals.

Get access to education and training, for both experts and students.

Amplify your voice locally to increase awareness on cancer prevention worldwide
DSC_0157
IMG_2548
Afbeelding van WhatsApp op 2023-12-20 om 15.51.12_a5c970e4
TAD06881
World Cancer Day 2024
PlayPlay
World Cancer Day 2024

The Cancer Prevention Forum took place on Sunday, February 4th, 2024, and raised awareness about different types of cancer (skin, breast and lung cancer) and ways to prevent them.

Meeting 3
IMG_2742
IMG_2670
TAD07252
DSC_0155
DSC_0142
previous arrow
next arrow

Publications

1. Racial Differences in Cancer Susceptibility and Survival: More Than the Color of the Skin? Özdemir BC, Dotto GP.Trends Cancer. (2017), 3:181-197. doi: 10.1016/j.trecan.2017.02.002.

Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast activation. Clocchiatti, A., S. Ghosh, M.G. Procopio, L. Mazzeo, P. Bordignon, P. Ostano, S. Goruppi, G. Bottoni, A. Katarkar, M. Levesque, P. Kölblinger, R. Dummer, V. Neel, B.C. Ozdemir, and G.P. Dotto. J. Clin. Invest. (2018). 128: p. 5531-5548 doi: 10.1172/JCI99159.

3. Sex Differences in Efficacy and Toxicity of Systemic Treatments: An Undervalued Issue in the Era of Precision Oncology. Özdemir, B.C., Csajka, C., Dotto, G.P., and Wagner, A.D. (2018). J Clin Oncol, 36, 2680-2683 JCO2018783290.

4. The challenges of modelling hormone receptor-positive breast cancer in mice. Özdemir BC, Sflomos G, Brisken C. (2018) Endocr Relat Cancer.:R319-R330. doi: 10.1530/ERC-18-0063.